Hashimoto's Disease

The grounding supports an autoimmune cause, specifically loss of immune tolerance to thyroid antigen. The literature also links the disease with genetic factors and with immune dysregulation involving inflammatory cytokines. No single non-autoimmune cause is established in the supplied material.

The disease process involves autoimmune attack on the thyroid, with thyroid autoantibodies as a defining feature. The supplied reviews describe loss of immune tolerance to thyroid antigen and disturbed interactions between thyroid hormones, minerals, and the immune system. Inflammatory cytokines are also described as playing a decisive role in the pathophysiological process.

The supplied material supports coexistence with other autoimmune intestinal diseases, especially celiac disease and non-celiac wheat sensitivity. It also indicates that altered gut barrier function and dysbiosis may be associated with autoimmune thyroid disease. Genetic susceptibility is also supported as a covered aspect, but no specific risk variants are provided.

The supplied grounding does not provide a clear treatment standard for Hashimoto disease. Selenium is co-studied, suggesting interest in mineral-based adjunctive approaches, but no treatment recommendation or modality is explicitly supported. Therefore this field is not supported by the provided material.